Primary Central Nervous System Posttransplant Lymphoproliferative Disease in a Bilateral Transfemoral Lower Extremity Transplantation Recipient

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

Andrés JM Ferreri, Michele Reni, Marco Foppoli et al. · The Lancet · 2009 · 662 citations · Full text

Medicine, Oncology, Pharmacology +10

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

Ralf Ulrich Trappe, Stephan Oertel, Véronique Leblond et al. · The Lancet Oncology · 2011 · 386 citations

Medicine, Immunology, Oncology +9

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

Servi J.C. Stevens, Erik A.M. Verschuuren, Inge Pronk et al. · Blood · 2001 · 327 citations · Full text

Medicine, Hematology, Immunology +9

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

Andrew M. Evens, Kevin A. David, Irene Helenowski et al. · Journal of Clinical Oncology · 2010 · 317 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Treatment of PTLD with Rituximab or Chemotherapy

Rebecca Elstrom, C. Andreadis, Nicole A. Aqui et al. · American Journal of Transplantation · 2006 · 260 citations · Full text

Medicine, Immunology, Oncology +13